We are Sorry, This Page doesn't Exist
Denali Therapeutics presents results from Phase 1/1b studies of BIIB122/DNL151
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Strongbridge presents results from Pivotal Phase 3 LOGICS Study of RECORLEV
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gamida Cell presents efficacy results from Phase 3 omidubicel study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck presents results from Phase 1 trial of islatravir subdermal implant
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Casi: BioInvent presents "positive" results from Phase I/IIa trial of BI-1206
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Otonomy announces top-line results from Phase 1/2 trial of OTO-413
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Medicenna Announces March 31, 2020 Year-End Results
-Â Â Â Â End of Phase 2 meeting package for MDNA55 to be submitted in Q2 2020--Â Â Â Â IND submissi.....»»
Medicenna Announces March 31, 2020 Year-End Results
-Â Â Â Â End of Phase 2 meeting package for MDNA55 to be submitted in Q.....»»
InflaRx Reports Full Year 2019 Financial & Operating Results
End of Phase 2 FDA meeting scheduled to discuss the path forward for IFX-1 in Hidradenitis Suppurativa Initial promising results reported in Pyoderma Gangraenosum Part 1 of adaptive randomized trial in severe COVID-19 pneumonia fully enrolled Exe.....»»
Inovio presents interim results from Phase 2 trial of VGX-3100
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mersana Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Updates
XMT-1536 Phase 1 dose escalation data update selected for late-breaker oral presentation at upcoming Society of Gynecologic Oncology (SGO) 2020 Annual Meeting on Women's Cancer XMT-1536 interim Phase 1 dose expansion data to be .....»»
BioDelivery Sciences presents phase 1 results of BELBUCA in respiratory drive
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sorrento Therapeutics presents "positive" interim results of Phase 1b RTX trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Otonomy Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Results from three clinical trials expected in 2020 including the Phase 3 trial of OTIVIDEX™ in Ménière's disease Current capital funds operations into 2021 Conference call and webcast today at 4:.....»»
Otonomy presents preclinical results for GJB2 collaboration, cisplatin program
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Otonomy expects results from Phase 1/2 OTO-413 trial in 2H20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Otonomy expects results from Phase 1/2 OTO-313 trial in 2Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Otonomy expects results from Phase 3 OTIVIDEX trial in 3Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Provectus presents preliminary results from Phase 1 trial of PV-10
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Puma Biotechnology presents Phase II results of neratinib in breast cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»